<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17722" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anton Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Das</surname>
            <given-names>Joe M.</given-names>
          </name>
          <aff>Imperial College Healthcare NHS Trust, London</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Naqvi</surname>
            <given-names>Imama A.</given-names>
          </name>
          <aff>Temple University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Joe Das declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Imama Naqvi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17722.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Anton-Babinski syndrome, also known as ABS or Anton syndrome, is visual anosognosia, or denial of vision loss, associated with confabulation, or making up experiences to compensate for memory loss, in the setting of cortical blindness. This activity reviews the evaluation and treatment of Anton syndrome and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of Anton syndrome.</p></list-item><list-item><p>Outline the typical presentation of a patient with Anton syndrome.</p></list-item><list-item><p>Review the risk factors for developing Anton syndrome.</p></list-item><list-item><p>Describe how an optimally functioning interprofessional team would coordinate care to enhance outcomes for patients with Anton syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17722&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17722">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17722.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Cortical blindness is among the rare neurological conditions resulting in binocular vision loss due to insult to the occipital cortex.&#x000a0;Anton-Babinski syndrome (Anton syndrome or ABS) is visual anosognosia (denial of loss of vision) associated with confabulation (defined as the emergence of memories of events and experiences which never took place) in the setting of obvious visual loss and cortical blindness.<xref ref-type="bibr" rid="article-17722.r1">[1]</xref></p>
        <p>It is essentially neurological visual impairment/disturbance resulting from abnormality or damage in the brain rather than due to eye abnormalities.&#x000a0;</p>
        <p>The first description of ABS dates back to the Roman era when Seneca, a Roman philosopher and politician, described the case of Harpaste, a slave who acutely became blind. She used to deny her illness and argue irrationally about room darkness and constantly ask her attendants to change quarters. This case demonstrates the main symptoms of ABS, including acutely acquired blindness and anosognosia in the presence of relatively well-preserved cognition.<xref ref-type="bibr" rid="article-17722.r2">[2]</xref></p>
        <p>The next documented description of visual anosognosia was made by the French Renaissance writer Michel de Montaigne (1533 - 1592), who described a nobleman who denied his blindness. In 1895, the Austrian psychiatrist and neurologist Gabriel Anton (1858 - 1933) described the case of Juliane Hochriehser, a 69-year-old dairymaid who had anosognosia with cortical deafness due to a lesion on her both temporal lobes.&#x000a0;He also outlined other cases of patients with objective blindness and deafness who denied their deficits. In 1914, the French-Polish neurologist Joseph Fran&#x000e7;ois Babinski (1857 - 1932) used for the first time the term &#x0201c;anosognosia&#x0201d; to describe the unawareness of the deficit in patients with hemiplegia.<xref ref-type="bibr" rid="article-17722.r1">[1]</xref></p>
        <p>In 1920 Meyer first reported occipital lobe infarction and postulated compression of branches of the posterior cerebral artery as the causal factor for ABS.<xref ref-type="bibr" rid="article-17722.r3">[3]</xref></p>
      </sec>
      <sec id="article-17722.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Causes include<xref ref-type="bibr" rid="article-17722.r3">[3]</xref><xref ref-type="bibr" rid="article-17722.r4">[4]</xref><xref ref-type="bibr" rid="article-17722.r5">[5]</xref><xref ref-type="bibr" rid="article-17722.r6">[6]</xref><xref ref-type="bibr" rid="article-17722.r7">[7]</xref><xref ref-type="bibr" rid="article-17722.r8">[8]</xref><xref ref-type="bibr" rid="article-17722.r9">[9]</xref><xref ref-type="bibr" rid="article-17722.r10">[10]</xref><xref ref-type="bibr" rid="article-17722.r11">[11]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>An ischemic stroke involving bilateral occipital lobes due to the involvement of posterior cerebral arteries (most common cause)</p>
          </list-item>
          <list-item>
            <p>Cardiac surgery</p>
          </list-item>
          <list-item>
            <p>Cerebral angiography</p>
          </list-item>
          <list-item>
            <p>MELAS (mitochondrial myopathy, encephalomyopathy, lactic acidosis, and stroke-like episodes)</p>
          </list-item>
          <list-item>
            <p>Preeclampsia</p>
          </list-item>
          <list-item>
            <p>Obstetric hemorrhage</p>
          </list-item>
          <list-item>
            <p>Head trauma</p>
          </list-item>
          <list-item>
            <p>Adrenoleukodystrophy</p>
          </list-item>
          <list-item>
            <p>Hypertensive encephalopathy</p>
          </list-item>
          <list-item>
            <p>Angiitis (autoimmune) of the central nervous system</p>
          </list-item>
          <list-item>
            <p>Progressive multifocal leukoencephalopathy, in the setting of human immunodeficiency virus infection</p>
          </list-item>
          <list-item>
            <p>Multiple sclerosis</p>
          </list-item>
          <list-item>
            <p>Posterior reversible encephalopathy syndrome (PRES) secondary to SARS-CoV-2 (COVID-19) pneumonia</p>
          </list-item>
          <list-item>
            <p>Fat embolism syndrome</p>
          </list-item>
          <list-item>
            <p>Trousseau syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17722.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Anton-Babinski syndrome is a very rare condition with only 28 cases published between 1965 and 2016.<xref ref-type="bibr" rid="article-17722.r12">[12]</xref></p>
      </sec>
      <sec id="article-17722.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Pathophysiology of blindness:</bold>
</p>
        <p>The ability to recognize visually presented objects depends on the integrity of the following:</p>
        <p>1. Visual pathways</p>
        <p>2. The primary visual area of the cerebral cortex (Brodmann area 17)</p>
        <p>3. The secondary visual cortex, lying just anterior to area 17 (Brodmann areas 18 and 19) of the occipital lobe</p>
        <p>4. The angular gyrus of the dominant hemisphere (Brodmann area 39) -&#x000a0; visual association area.</p>
        <p>
<bold>Patterns of visual deficits in ABS:</bold>
</p>
        <p>1. Blindness: Although the anterior visual tracts are intact,&#x000a0;bilateral occipital brain damage results in blindness.&#x000a0;</p>
        <p>2. Gunbarrel vision: Tiny islands of vision sometimes persist, and in such cases, the patient may report that vision fluctuates as images are captured in the preserved portions; in rare instances, only peripheral vision is lost, and central vision is spared, resulting in gun-barrel vision</p>
        <p>3. Perception of movements alone: Movement of objects may be perceived, either consciously (Riddoch syndrome) or unconsciously (blindsight)</p>
        <p>4. Motion blindness: Patients&#x000a0;will be able to see objects but will not be able to appreciate their motion. This may be explained by the presence of projections from the lateral geniculate nucleus, to both the primary visual cortex via the optic radiations and the motion-selective middle temporal area (MT or V5)</p>
        <p>5. Charles Bonnet syndrome: In this condition, the patient will have a loss of vision (due to any reason), but insight will be preserved. Such patients may experience visual hallucinations containing images of unfamiliar objects and people.</p>
        <p><bold>Pathophysiology of anosognosia</bold><xref ref-type="bibr" rid="article-17722.r13">[13]</xref>:</p>
        <p>Theories to explain the unawareness of deficit on the Anton-Babinsky syndrome:</p>
        <p>1. Disconnection phenomena:</p>
        <p>a. Conscious awareness system (CAS): This function of this system is to monitor the inputs from all the sensory organs and is located in the bilateral parietal lobes. Another system integrating the inputs is located within the bilateral frontal lobes, and this is connected with the former system. This interconnected system helps in&#x000a0;performing complex cognitive tasks. In Anton-Babinski syndrome, damage of association pathways between the visual cortex and CAS would be responsible for the lack of awareness of the visual deficit.</p>
        <p>b. Disconnection of the visual area from language area: This makes the patient fabulate answers as he/she will be not able to describe the visual stimulus.</p>
        <p>c. Overaction of the secondary visual pathway: A secondary visual system is located in the superior colliculus, pulvinar, and temporoparietal regions. This system will usually send impulses to the visual association cortex (visual monitor). If there is no transmission of impulse in the geniculo-calcarine pathway, the secondary visual pathway will gain predominance and results in fabulation in blind patients.&#x000a0;</p>
        <p>2. Neuropsychological mechanisms:</p>
        <p>a. Defective visual monitor: This leads to incorrect interpretation of images.</p>
        <p>b. The presence of false-positive feedback from visual monitor: This leads to a perception of false images, which in turn leads the speech areas to come out with an abnormal response.</p>
        <p><bold>Pathophysiology of confabulatio</bold>n<xref ref-type="bibr" rid="article-17722.r1">[1]</xref>:</p>
        <p>Patients start to confabulate to fill in the missing sensory input. Anton suggested that functioning speech and language areas will be disconnected from the damaged visual pathways. If there are no proper sensory visual inputs, the functioning speech areas may confabulate a response. In this, patients adamantly claim that they are capable of seeing and/ or experiencing strange visual hallucinatory episodes, consequently resulting in confabulation.</p>
        <p>
<bold>In short, ABS can be caused by lesions along the following structures:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Visual&#x000a0;cortices</p>
          </list-item>
          <list-item>
            <p>Bilateral lateral geniculate bodies</p>
          </list-item>
          <list-item>
            <p>Posterior limbs of the internal capsules</p>
          </list-item>
          <list-item>
            <p>Optic radiations</p>
          </list-item>
          <list-item>
            <p>Corpus callosum</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17722.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Criteria for diagnosis of cortical blindness:</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>Loss of all visual sensations, including the perception of light and dark</p>
          </list-item>
          <list-item>
            <p>Loss of menace reflex</p>
          </list-item>
          <list-item>
            <p>Preservation of light and accommodation pupillary reflexes</p>
          </list-item>
          <list-item>
            <p>Normal fundoscopic examination, and</p>
          </list-item>
          <list-item>
            <p>Preservation of ocular movements</p>
          </list-item>
        </list>
        <p>
<bold>The classical description of clinical features of ABS:</bold>
</p>
        <p>Though the patient is blind, he will behave and talk as if he has normal vision. Attention is aroused; however, when the patient is found to collide with pieces of furniture, to fall over objects, and to experience difficulty in finding his way around. They may try to walk through a wall or a closed door on their way from one room to another. Suspicion is still further alerted when they begin to describe people and objects around them who do not exist.&#x000a0;Mental confusion may also be seen. Patients with ABS may give excuses for their blindness. They may explain that their inability to see is because of the lack of proper lighting, and they may try their best to prove that they are not blind, thereby putting themselves in danger.</p>
      </sec>
      <sec id="article-17722.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A proper history and physical examination should be followed by:</p>
        <list list-type="bullet">
          <list-item>
            <p>Detailed neuroophthalmological evaluation including testing for visual acuity and the field of vision</p>
          </list-item>
          <list-item>
            <p>Magnetic resonance imaging of the brain</p>
          </list-item>
          <list-item>
            <p>Echocardiogram and carotid doppler to rule out the cardiovascular cause of stroke</p>
          </list-item>
          <list-item>
            <p>Visual evoked potential in confusing cases and pediatric patients</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17722.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of ABS is based on the etiology. If due to stroke, the usual treatment is with antiplatelet agents. Any cardiovascular condition causing stroke should be ruled out.</p>
      </sec>
      <sec id="article-17722.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>ABS syndrome needs to be differentiated from:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cerebral visual impairment</p>
          </list-item>
          <list-item>
            <p>Delayed visual development</p>
          </list-item>
          <list-item>
            <p>Homonymous hemianopia</p>
          </list-item>
          <list-item>
            <p>Lack of facial recognition</p>
          </list-item>
          <list-item>
            <p>Visual agnosia</p>
          </list-item>
          <list-item>
            <p>Visual neglect</p>
          </list-item>
          <list-item>
            <p>Visual perceptual disorders</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17722.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Recovery of visual function has occurred in conditions causing ABS, such as hypertensive encephalopathy and cortical hypoperfusion. In these conditions, correction of the causative factor may lead to the resolution of symptoms.&#x000a0;The outcome of cortical blindness depends&#x000a0;on the age of the patient, etiology, severity, duration, initial recovery time, medical history.</p>
      </sec>
      <sec id="article-17722.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Patients suffering from ABS are prone to trauma as they pretend to have a vision and try to keep moving around.</p>
      </sec>
      <sec id="article-17722.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient counseling can be done based on etiology. But confabulation may be difficult to treat with counseling alone.</p>
      </sec>
      <sec id="article-17722.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Before diagnosing a patient as having ABS, proper ophthalmological evaluation should be done. Discussion regarding the etiology of ABS should be done with neuroradiologists, neurologists, and internists. A team of specialty-trained nurses and clinicians is necessary to evaluate and provide management of this condition for the best outcomes.</p>
      </sec>
      <sec id="article-17722.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17722&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17722">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/anton-syndrome-antons-blindness/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17722">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17722/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17722">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17722.s15">
        <title>References</title>
        <ref id="article-17722.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maddula</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lutton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Keegan</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Anton's syndrome due to cerebrovascular disease: a case report.</article-title>
            <source>J Med Case Rep</source>
            <year>2009</year>
            <month>Sep</month>
            <day>09</day>
            <volume>3</volume>
            <fpage>9028</fpage>
            <pub-id pub-id-type="pmid">20226004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andr&#x000e9;</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Seneca and the First Description of Anton Syndrome.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>511</fpage>
            <page-range>511-513</page-range>
            <pub-id pub-id-type="pmid">29979335</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rath</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Anton syndrome and cortical blindness due to bilateral occipital infarction.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>1989</year>
            <season>Oct-Dec</season>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>196</fpage>
            <pub-id pub-id-type="pmid">2638312</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen-Lam</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kiernan</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Acute cortical blindness due to posterior reversible encephalopathy.</article-title>
            <source>J Clin Neurosci</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>1182</fpage>
            <page-range>1182-5</page-range>
            <pub-id pub-id-type="pmid">18501611</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alemdar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iseri</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Selekler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Budak</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Demirci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Komsuoglu</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>MELAS presented with status epilepticus and Anton-Babinski syndrome; value of ADC mapping in MELAS.</article-title>
            <source>J Neuropsychiatry Clin Neurosci</source>
            <year>2007</year>
            <season>Fall</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>482</fpage>
            <page-range>482-3</page-range>
            <pub-id pub-id-type="pmid">18070866</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aldrich</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Alessi</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Gilman</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cortical blindness: etiology, diagnosis, and prognosis.</article-title>
            <source>Ann Neurol</source>
            <year>1987</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>149</fpage>
            <page-range>149-58</page-range>
            <pub-id pub-id-type="pmid">3827223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trifiletti</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Hayes-Rosen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pavone</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Anton-Babinski syndrome in a child with early-stage adrenoleukodystrophy.</article-title>
            <source>Eur J Neurol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>e11</fpage>
            <page-range>e11-2</page-range>
            <pub-id pub-id-type="pmid">17250706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alp</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Bozbu&#x0011f;a</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tuncer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Yakut</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Transient cortical blindness after coronary angiography.</article-title>
            <source>J Int Med Res</source>
            <year>2009</year>
            <season>Jul-Aug</season>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>1246</fpage>
            <page-range>1246-51</page-range>
            <pub-id pub-id-type="pmid">19761711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elhassan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saidahmed</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Adebayo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Archibald</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Jan</month>
            <day>19</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>e12794</fpage>
            <pub-id pub-id-type="pmid">33500867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirza</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Acharya</surname>
                <given-names>PU</given-names>
              </name>
              <name>
                <surname>Austine</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Transient cortical blindness in fat embolism syndrome---a diagnostic enigma.</article-title>
            <source>Chin J Traumatol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-82</page-range>
            <pub-id pub-id-type="pmid">33627294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cao</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Anton's syndrome as a presentation of Trousseau syndrome involving the bilateral optic radiation.</article-title>
            <source>J Int Med Res</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>48</volume>
            <issue>11</issue>
            <fpage>300060520972907</fpage>
            <pub-id pub-id-type="pmid">33233982</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Anbarasan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Anton syndrome as a result of MS exacerbation.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>e19</fpage>
            <page-range>e19-e22</page-range>
            <pub-id pub-id-type="pmid">29185543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17722.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGlynn</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Schacter</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Unawareness of deficits in neuropsychological syndromes.</article-title>
            <source>J Clin Exp Neuropsychol</source>
            <year>1989</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-205</page-range>
            <pub-id pub-id-type="pmid">2647781</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
